Automate Analysis Results Metadata in the Define-XML v2.0. Hong Qi, Majdoub Haloui, Larry Wu, Gregory T Golm Merck & Co., Inc.

Similar documents
Introduction to ADaM and What s new in ADaM

How to write ADaM specifications like a ninja.

Creating an ADaM Data Set for Correlation Analyses

Implementing CDISC Using SAS. Full book available for purchase here.

esubmission - Are you really Compliant?

Use of Traceability Chains in Study Data and Metadata for Regulatory Electronic Submission

DCDISC Users Group. Nate Freimark Omnicare Clinical Research Presented on

Step Up Your ADaM Compliance Game Ramesh Ayyappath & Graham Oakley

Applying ADaM Principles in Developing a Response Analysis Dataset

Paper DS07. Generating Define.xml and Analysis Result Metadata using Specifications, Datasets and TFL Annotation

ADaM and traceability: Chiesi experience

An Efficient Solution to Efficacy ADaM Design and Implementation

From Implementing CDISC Using SAS. Full book available for purchase here. About This Book... xi About The Authors... xvii Acknowledgments...

Material covered in the Dec 2014 FDA Binding Guidances

PhUSE Paper TT05

Traceability Look for the source of your analysis results

Xiangchen (Bob) Cui, Tathabbai Pakalapati, Qunming Dong Vertex Pharmaceuticals, Cambridge, MA

Dealing with changing versions of SDTM and Controlled Terminology (CT)

Beyond OpenCDISC: Using Define.xml Metadata to Ensure End-to-End Submission Integrity. John Brega Linda Collins PharmaStat LLC

ADaM Compliance Starts with ADaM Specifications

A Taste of SDTM in Real Time

Doctor's Prescription to Re-engineer Process of Pinnacle 21 Community Version Friendly ADaM Development

The Implementation of Display Auto-Generation with Analysis Results Metadata Driven Method

PharmaSUG Paper AD03

Out-of-the-box %definexml

PharmaSUG Paper DS24

Riepilogo e Spazio Q&A

PharmaSUG DS05

Improving Metadata Compliance and Assessing Quality Metrics with a Standards Library

Paper DS07 PhUSE 2017 CDISC Transport Standards - A Glance. Giri Balasubramanian, PRA Health Sciences Edwin Ponraj Thangarajan, PRA Health Sciences

Why organizations need MDR system to manage clinical metadata?

Optimization of the traceability when applying an ADaM Parallel Conversion Method

It s All About Getting the Source and Codelist Implementation Right for ADaM Define.xml v2.0

Legacy to SDTM Conversion Workshop: Tools and Techniques

Deriving Rows in CDISC ADaM BDS Datasets

SAS Application to Automate a Comprehensive Review of DEFINE and All of its Components

Programming checks: Reviewing the overall quality of the deliverables without parallel programming

ADaM Implementation Guide Prepared by the CDISC ADaM Team

How to handle different versions of SDTM & DEFINE generation in a Single Study?

Study Data Reviewer s Guide Completion Guideline

ADaM Reviewer s Guide Interpretation and Implementation

Edwin Ponraj Thangarajan, PRA Health Sciences, Chennai, India Giri Balasubramanian, PRA Health Sciences, Chennai, India

Revision of Technical Conformance Guide on Electronic Study Data Submissions

Lex Jansen Octagon Research Solutions, Inc.

PharmaSUG Paper DS06 Designing and Tuning ADaM Datasets. Songhui ZHU, K&L Consulting Services, Fort Washington, PA

Introduction to ADaM standards

Traceability in the ADaM Standard Ed Lombardi, SynteractHCR, Inc., Carlsbad, CA

The Benefits of Traceability Beyond Just From SDTM to ADaM in CDISC Standards Maggie Ci Jiang, Teva Pharmaceuticals, Great Valley, PA

Robust approach to create Define.xml v2.0. Vineet Jain

Making a List, Checking it Twice (Part 1): Techniques for Specifying and Validating Analysis Datasets

Pharmaceuticals, Health Care, and Life Sciences. An Approach to CDISC SDTM Implementation for Clinical Trials Data

Standards Driven Innovation

Creating Define-XML version 2 including Analysis Results Metadata with the SAS Clinical Standards Toolkit

CDASH Standards and EDC CRF Library. Guang-liang Wang September 18, Q3 DCDISC Meeting

Study Data Reviewer s Guide

Metadata and ADaM.

NCI/CDISC or User Specified CT

PhUSE US Connect 2019

ADaM Implementation Guide Status Update

Leveraging Study Data Reviewer s Guide (SDRG) in Building FDA s Confidence in Sponsor s Submitted Datasets

Clinical Metadata Metadata management with a CDISC mindset

From SAP to BDS: The Nuts and Bolts Nancy Brucken, i3 Statprobe, Ann Arbor, MI Paul Slagle, United BioSource Corp., Ann Arbor, MI

Experience of electronic data submission via Gateway to PMDA

Pooling strategy of clinical data

PharmaSUG Paper PO22

Module I: Clinical Trials a Practical Guide to Design, Analysis, and Reporting 1. Fundamentals of Trial Design

PMDA Valida+on Rules. Preparing for your next submission to Japanese Pharmaceu6cals and Medical Devices Agency. Max Kanevsky December 10, 2015

TS04. Running OpenCDISC from SAS. Mark Crangle

ADaM for Medical Devices: Extending the Current ADaM Structures

Comparison of FDA and PMDA Requirements for Electronic Submission of Study Data

AUTOMATED CREATION OF SUBMISSION-READY ARTIFACTS SILAS MCKEE

DIA 11234: CDER Data Standards Common Issues Document webinar questions

Optimization of the traceability when applying an ADaM Parallel Conversion Method

CDISC SDTM and ADaM Real World Issues

PharmaSUG Paper DS-24. Family of PARAM***: PARAM, PARAMCD, PARAMN, PARCATy(N), PARAMTYP

Customer oriented CDISC implementation

An Alternate Way to Create the Standard SDTM Domains

Working with Composite Endpoints: Constructing Analysis Data Pushpa Saranadasa, Merck & Co., Inc., Upper Gwynedd, PA

Pooling Clinical Data: Key points and Pitfalls

Cost-Benefit Analysis of Retrospective vs. Prospective Data Standardization

What is the ADAM OTHER Class of Datasets, and When Should it be Used? John Troxell, Data Standards Consulting

Submission-Ready Define.xml Files Using SAS Clinical Data Integration Melissa R. Martinez, SAS Institute, Cary, NC USA

Considerations on creation of SDTM datasets for extended studies

Preparing the Office of Scientific Investigations (OSI) Requests for Submissions to FDA

Study Data Technical Conformance Guide (TCG)

CBER STUDY DATA STANDARDS UPDATE

PharmaSUG 2014 PO16. Category CDASH SDTM ADaM. Submission in standardized tabular form. Structure Flexible Rigid Flexible * No Yes Yes

Managing your metadata efficiently - a structured way to organise and frontload your analysis and submission data

OpenCDISC Validator 1.4 What s New?

Sandra Minjoe, Accenture Life Sciences John Brega, PharmaStat. PharmaSUG Single Day Event San Francisco Bay Area

PhUSE Paper SD09. "Overnight" Conversion to SDTM Datasets Ready for SDTM Submission Niels Mathiesen, mathiesen & mathiesen, Basel, Switzerland

Data Science Services Dirk Engfer Page 1 of 5

Updates on CDISC Standards Validation

STUDY DATA TECHNICAL CONFORMANCE GUIDE

From SDTM to displays, through ADaM & Analyses Results Metadata, a flight on board METADATA Airlines

Analysis Data Model Implementation Guide Version 1.1 (Draft) Prepared by the CDISC Analysis Data Model Team

SDTM Implementation Guide Clear as Mud: Strategies for Developing Consistent Company Standards

Some Considerations When Designing ADaM Datasets

Yes! The basic principles of ADaM are also best practice for our industry Yes! ADaM a standard with enforceable rules and recognized structures Yes!

Prove It! Importance and Methodologies of Validation in Clinical Trials Reporting

Transcription:

Automate Analysis Results Metadata in the Define-XML v2.0 Hong Qi, Majdoub Haloui, Larry Wu, Gregory T Golm Merck & Co., Inc., USA 1

Topics Introduction Analysis Results Metadata (ARM) Version 1.0 o o o What is ARM? Why ARM? ARM Requirements Automate ARM Generation in Define o o Conclusion Current Process Enhanced Process 2

Introduction (1) Compliance with regulatory requirements o Successful new drug submission o Additional effort at each step of the process Understanding the regulatory requirements o Streamline the process Good planning of submission package in the early stage o Maintain high quality 3

Introduction (Cont.) Challenge gathering the details for the ARM of Define-XML from reports and programs at the last minute o Efficiency o Quality Focus of this presentation o ARM requirements o Effective approach 4

What is ARM? A document that identifies the critical analyses Provides traceability from results in a statistical display to the analysis data used to create it o o Document the analyses performed Provide the regulatory reviewer with the means to trace results back to their source documents (programs, datasets, and statistical analysis plans) 5

What is ARM? (Cont.) Purpose o Submission to regulatory agencies United States Food and Drug Administration (FDA) Japan Pharmaceutical and Medical Devices Agency (PMDA) o Exchange of analysis datasets and key results between other parties 6

What is ARM? (Cont.) CDISC ADaM Analysis Data Model Version 2.1 Analysis Results Metadata Specification Version 1.0 for Define-XML Version 2 o Released in January 2015 o https://www.cdisc.org/standards/foundational/ada m 7

Why ARM? Provides a fundamental principle of ADaM traceability Describes key components of significant analysis results Other sources o Text and links Result Save review time and expedite the drug approval o Identifying the critical analyses o Understanding and reproducing analysis results Meta data 8

Why ARM? (Cont.) A highly recommended ADaM metadata component o PMDA (Japan) is already asking for it (TCG section 4.1.2.1 Definition documents of datasets page 23) o FDA is interested Benefits o Provide ARM to assist the review Critical analyses Links between results, documentation, datasets Documenting the analyses performed o Has a potential to save significant time for the regulatory reviewer and expedite the drug approval 9

Why ARM? (Cont.) Sponsor s decision on which analyses to be displayed o ARM focus should be on primary and key secondary analysis results 10

ARM Requirement Table 1 Analysis Result Metadata fields Metadata Field Definition Source / Metadata Example A unique identifier for the specific analysis display Table/Figure number DISPLAY IDENTIFIER Table 14-3.01 (such as a table or figure number) DISPLAY NAME Title of display, including additional information if needed to describe and identify the display (e.g., analysis population) Table/Figure title Primary Endpoint Analysis: ADAS Cog (11) - Change from Baseline to Week 24 LOCF RESULT IDENTIFIER PARAM Identifies the specific analysis result within a display when there are multiple analysis results on a display. The analysis parameter in the BDS analysis dataset that is the focus of the analysis result. Does not apply if the result is not based on a BDS analysis dataset. Table/Figure Analysis of dose response Define.xml variable section ADAS-Cog (11) Total Score PARAMCD Corresponds to PARAM in the BDS analysis dataset. Does not apply if the result is not based on a BDS analysis dataset. Define.xml variable section ACTOT11 11

ARM Requirement Metadata Fields Table 1 Analysis Result Metadata fields (Cont.) Metadata Field Definition Source / Metadata Example ANALYSIS VARIABLE The analysis variable being analyzed Define.xml variable section CHG REASON DATASET The rationale for performing this analysis. It indicates when the analysis was planned and the purpose of the analysis. The name of the dataset(s) used to generate the analysis result. Protocol and/or SAP Primary efficacy analysis as prespecified in protocol Define.xml Dataset section ADQSADAS SELECTION CRITERIA Specific and sufficient selection criteria for analysis subset and / or numerator. Protocol and/or SAP ITTFL='Y' and AVISIT='Week 24' and PARAMCD='ACTOT11' 12 DOCUMENTATION Textual description of the analysis performed. Protocol and/or SAP Linear model analysis of dose response; Refer to Figure 2 for details. SAP Section 10.1.1. PROGRAMMING STATEMENTS The software programming code used to perform the specific analysis including the model statement, and all technical specifications needed for reproducing the analysis Study SAS programs [SAS version 9.2] Refer to Figure 2

ARM Requirement Example of ARM Figure 1 Analysis Results Metadata (Summary) 13

ARM Requirement Example of ARM Figure 2 Analysis Results Metadata (Detail) 14

ARM Requirement Statistical Display in CSR ADQSADAS (PARAMCD = ACTOT and AVISIT = Week 24 and EFFFL = Y and ANL01FL = Y ) Analysis variable(s): CHG (Change from Baseline) 15 Figure 3 Example of an analysis table in CSR with some of the metadata annotations

Automate ARM Generation in Define Current Process o Identify the information needed for ARM when preparing the submission package o External pdf file: analysis-results-metadata.pdf o Linked to the define.xml o Issues Linked to analysis-results-metadata.pdf Time consuming Prone to errors Issues with linking found in the last minute during submission reviews 16

Automate ARM Generation in Define (Cont.) Enhanced Process o Goal: an efficient submission process with high quality o Strategies Proactively document the ARM components when the reports are being designed or generated Automate the ARM generation as an extension to Define.xml using Pinnacle 21 Enterprise tool 17

Automate ARM Generation in Define (Cont.) Enhanced Process (Cont.) o Tool: <ARM0template.xlsm>, a macro-enabled spreadsheet Study report tabs: ü Standards reports, therapeutic area reports ü With all the ARM components documented ahead ü Study specific information added for the selected reports Pinnacle 21 Enterprise required tabs ü Macro-enabled spreadsheet tabs that select and combine information from the study report tabs 18

Automate ARM Generation in Define (Cont.) <ARM0template.xlsm> Sample Study report tabs Pinnacle 21 Enterprise required tabs 19

Automate ARM Generation in Define (Cont.) Pinnacle 21 Enterprise required tabs in ARM0Template.xlsm, copied to the ADaM data specification, as the input file for Pinnacle 21 Enterprise ARM0Template.xlsm Tabs: Analysis Displays Analysis Results P000V00MK0000.xlsx (Data Specification) 20

Automate ARM Generation in Define (Cont.) 21 ARM generated by Pinnacle 21 Enterprise as part of Define.xml

Conclusion It is critical to fully understand the CDISC requirements and proactively plan the data collection for ARM in order to produce the ARM with high quality and cycle time reduction. Establishing an ARM template file to collect and store ARM components for both standards reports and therapeutic area specific reports ensures the effective implementation and governance of CDISC data standards across studies. 22

Acknowledgement Ellen Asam Mary Varughese Sapan Patel Amy Gillespie 23